Covid-19: Pfizer could have Omicron-targeted vaccine by March, says CEO


NEW YORK (Reuters): Pfizer Inc chief executive Albert Bourla on Monday (Jan 10) said a redesigned Covid-19 vaccine that specifically targets the Omicron coronavirus variant is likely needed and his company could have one ready to launch by March.

Bourla said Pfizer and partner BioNTech SE are working on both an Omicron-targeted vaccine version as well as a shot that would include both the previous vaccine as well as one targeted at the fast-spreading variant.

Get 30% off with our ads free Premium Plan!

Monthly Plan

RM13.90/month
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Covid-19 , Omicron , Pfizer

   

Next In World

Indonesian tsunami survivor holds on to hope for missing son after 20 years
South Korean opposition threatens to impeach Han over martial law counsel
Jeff Bezos says most people should take more risks. Here’s the science that proves he’s right
Bluesky finds with growth comes growing pains – and bots
How tech created a ‘recipe for loneliness’
New Zealand rejects Cook Islands passport plan
How data shared in the cloud is aiding snow removal
Brazil bridge collapses, spilling sulfuric acid into river
Do you have a friend in AI?
Slovak PM meets Putin to discuss transit of Russian gas

Others Also Read